Nexalin Technology company info

What does Nexalin Technology do?
Nexalin Technology (NASDAQ:NXL) is a company that specializes in developing advanced medical devices designed to address mental health and neuropsychiatric disorders without the use of pharmaceuticals. At the heart of its innovation is a non-invasive therapy technology, which aims at treating anxiety, depression, and insomnia through transcranial electrical stimulation. With a commitment to improving the standard of mental health care, Nexalin continues to invest in research and development to expand its product portfolio and reach. The company's objective is to offer effective, drug-free solutions for mental health conditions, making treatment accessible and reducing the stigma associated with traditional psychiatric medications.
Nexalin Technology company media
Company Snapshot

Is Nexalin Technology a public or private company?

key
Ownership
Public

How many people does Nexalin Technology employ?

people
Employees
6

What sector is Nexalin Technology in?

pie chart
Sector
Health Care

Where is the head office for Nexalin Technology?

location pin
Head Office
California, United States

What year was Nexalin Technology founded?

founded flag
Year Founded
2010
What does Nexalin Technology specialise in?
/Therapeutic Devices /Mental Health /Neurological Treatment /Drug-Free Therapy /Nexalin Device /Healthcare Technology

What are the products and/or services of Nexalin Technology?

Overview of Nexalin Technology offerings
Research and development in Transcranial Electrical Stimulation technologies.
Partnerships for clinical trials to validate and improve neuromodulation treatments.
Manufacturing and distribution of FDA-cleared neuromodulation devices.
Development of portable and user-friendly devices for home use.
Expanding global reach through regulatory approvals in new markets.

Who is in the executive team of Nexalin Technology?

Nexalin Technology leadership team
  • Ms. Marilyn  Elson
    Ms. Marilyn Elson
    Controller
  • Mr. Mark  White
    Mr. Mark White
    President, CEO, CFO & Director
  • Mr. John Patrick Claude
    Mr. John Patrick Claude
    Co-Founder and Director of Engineering & Development
  • Dr. David  Owens M.D.
    Dr. David Owens M.D.
    Chief Medical Officer & Director
  • Mr. Michael  Nketiah
    Mr. Michael Nketiah
    Senior Vice-President of Quality, Regulatory & Clinical Affairs